Your SlideShare is downloading. ×
0
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Disease State Plasma Newsflash - January 2014 - BBI Solutions

543

Published on

The BBI Solutions Disease State Plasma Newsflash gives details about our current inventory of disease state plasma, clinical samples and speciality blood products. This months features include our new …

The BBI Solutions Disease State Plasma Newsflash gives details about our current inventory of disease state plasma, clinical samples and speciality blood products. This months features include our new autoimmune products and our rare infectious disease products.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
543
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Inventory Newsflash January 2014 Disease State Plasma Capabilities Current Inventory Clinical Samples Capabilities Current Inventory Specialty blood products Capabilities Quality Partnership Results Innovation Inventory correct at time of publication
  • 2. Why choose BBI ?  Save time and optimise your success rate by selecting from our highly characterised disease state plasma units  Have confidence in supply sustainability by choosing a partner with global collections directly from hospitals and blood banks  No longer struggle to collect a representative set of samples – we have rare materials from early disease diagnosis available  Never question quality or traceability by choosing products collected with ethics approval and donor consent when relevant, stored at a HTA licenced facility Quick Links What’s New? Disease State Plasma Our Capabilities > Current Inventory > Clinical Samples Our Capabilities > Current Inventory > Speciality Blood Our Capabilities > How to order >
  • 3. What’s New? New Capabilities Autoimmune Disease State Plasma  A-GBM New Biosafety Level 3 labs set up at our site in South Africa New Defibrination Process offered on request for many of our DSP New Heat Inactivation Process available for many of our infectious DSP  A-RNP / A-SS-A  SAA Infectious Disease State Plasma*:  HTLV-1 / HTLV-2  Parvovirus B19  Hepatitis E Virus  Toxoplasma IgM / IgG / Negative  CMV IgM / IgG / Negative  Rubella IgM */ IgG / Negative * Arriving in February Newly Sourced Products
  • 4. Our Capabilities | Disease State Plasma Infectious Disease Chlamydia IgG / IgM CMV IgG / IgM / Negative - NEW EBV IgG / IgM H. Pylori HAV IgG / IgM HCV IgG HBsAg HBc IgM / Total Ab HBeAg / HBeAb HIV 1 HIV 2 - NEW HIV O HSV 2 IgG / IgM HTLV-1 - NEW HTLV-2 - NEW HEV - NEW Lyme IgG / IgM Malaria - NEW Parvovirus B19 Rubella IgG / Negative – NEW Syphilis IgG / IgM Toxoplasma IgG / IgM / Negative - NEW Autoimmune Anti-GBM ANCA (Anti-MPO / Anti-PR3) Celiac Disease Crohn’s Disease Gliadin Antibodies IgA / IgG HAMA Rheumatoid Factor SLE Tissue Transglutaminase Abs Anti-RNP / Anti-SSA - NEW Cardiac Cholesterol HDL Hypertension LDL Triglyceride Autoimmune Thyroid Disease Anti-Tg Anti-TPO Graves Disease Hashimoto’s Disease Drugs of Abuse CDT Inflammation / Allergy CRP SAA Specific IgE (Allergy) Biochemistry Diabetes Glucose Vitamin D HbA1c Diagnosis (Type I / II) Organ Failure / Impairment Renal Failure Kidney Transplant Liver Transplant Pregnancy Amniotic Fluid Pregnancy Serum Chronological Bulk Urine Other Biomaterials CSF Urine Saliva Cord Serum
  • 5. Current Inventory | Disease State Plasma Infectious Diseases Product Code Quantitative results & other markers Tested Volume available in stock (ml) Collection Method FDA Tested Negative for other virals SH265 HAV IgM >6,000 ml Apheresis Yes HBV SH256 Hep B Core IgM Ab Hep B Core Total Ab Hep B e Ag Hep B e Ab >25,000 ml Recovered Yes HCV SH259 Viral load Genotype ~1,000 ml Recovered Yes HIV SH315 RNA+, Ab+ Viral Load Genotype >20,000 ml Recovered Yes Syphilis SH266 TPHA, RPR, IgM >9,000 ml Recovered Yes Toxoplasma SH275 Toxo IgM >1,000 ml Recovered Yes Disease Type HAV
  • 6. Current Inventory | Disease State Plasma Autoimmune / Non-infectious Diseases Volume available in stock (ml) Collection Method FDA Tested Negative for other virals Disease Type Product Code Quantitative results A-GBM SH336 Yes >11,000 ml Apheresis Yes dsDNA SH237 Yes >10,000 ml Apheresis Yes p-ANCA (MPO) SH152 Yes >12,000 ml Apheresis Yes SAA SH127 Yes >12,000 ml Apheresis Yes Anti-RNP / Anti-SS-A (Ro) SH293 Yes >6,000ml Apheresis Yes Celiac Disease SH235 Yes >1,000 ml Apheresis Yes Thyroid Disease SH245 / SH244 Yes >100,000 ml Apheresis CE marked Allergy / Raised IgE SH166 / SH234 Yes >5,000 ml Apheresis Yes Pregnancy (1st / 2nd / 3rd trimester) SH285 / SH283 / SH284 Yes >10,000 ml Apheresis Yes Renal Failure SH507 Yes >3,000 ml Apheresis Yes Contraceptive Pill Positive SH312 No >4,000 ml Apheresis Yes
  • 7. Our Capabilities | Clinical Samples Infectious Disease Chlamydia pneumoniae IgA/IgG Chlamydia trachomatis IgA/IgG CMV IgG / IgM / Negative EBV HCV IgG HBsAg / Anti-HBs HBc IgM / Total Ab HBeAg / HBeAb HEV HIV 1 / 2 / O HTLV-1 / HTLV-2 Malaria Measles IgG Mycoplasma pneumoniae Parvovirus B19 Rubella IgM / IgG / Negative Sepsis Syphilis IgG / IgM Toxo IgG / IgM / Negative Yersinia IgG / IgM Autoimmune ASO Anti-Cardiolipin Anti-CCP Anti-dsDNA Anti-GBM Anti-Nuclear Antibodies (Includes: SS-A/Ro, SS-B/La, Sm, RNP Jo-1, PM-SCL, KU, Centromere, AMA-M2, RIB-P, RO52) Anti-Tg Anti-TPO ANCA (Anti-MPO / Anti-PR3) Celiac Disease Crohn’s Disease Gliadin Antibodies IgA / IgG HAMA Histone Antibodies Rheumatoid Factor SLE Tissue Transglutaminase Abs Biochemistry Vitamin D Bilirubin (Total) Calcium Potassium CRP Neurological Alzheimer’s Disease NSE Allergy Raised Specific IgE Thyroid Free T3 (Triiodothyronine) Free T4 (Thyroxine) Parathyroid Hormone (PTH) TSH Pregnancy hCG Pre-eclampsia Pregnancy serum Cardiac Cholesterol CK-MB D Dimer HDL Hypertension LDL Myoglobin NT proBNP Triglyceride Troponin I Drugs of Abuse Urine CDT Diabetes HbA1c Diagnosis (Type I / II) Organ Failure/Impairment Renal Failure Hepatic Impairment Oncology AFP CA 125 CA 15-3 CA 19-9 CEA CYFRA PSA Endocrine Cortisol FSH LH Oestradiol Progesterone Prolactin SHBG Testosterone
  • 8. Current Inventory Infectious Disease Panels Panel specifications      Citrated plasma Extensive donor demographics Tested for HIV1 & 2 Abs, HBsAg, HCV Ab, HIV1/HBV/HCV PCR and Syphilis Individual donors (no duplicates) Donor consent Code no. Description Type Characteristics SHK510-4G HIV Plasma Panel Genotyped  Genotypes B, C, F and K  Testing results for multiple markers  Quantitative viral load result SHK510-4HC HIV Plasma Panel Highly Characterised  Testing results for multiple markers  Quantitative viral load result SHK256-4RS HBsAg Plasma Panel Rare specimen SHK259-4HC HCV Plasma Panel Highly Characterised  Quantitative viral load result  Genotyping results  Semi-quantitative methods for serology / NAT SHK266-4HC Syphilis Plasma Panel Highly characterised  Testing results for multiple markers  Syphilis IgM status SHK505-0 SH505-1 SHK505-2 Toxoplasma Plasma Panel Characterised SG202-4 Parvovirus Plasma Panel Characterised  Rare combination of HBV markers, including early stages  Testing results for multiple markers  Quantitative IgG & semi-quantitative IgM results  IgM avidity testing data  Consecutive samples over 7 - 14 days  IgG & IgM levels measured by PCR & ELISA
  • 9. Current Inventory | Clinical Samples Non-Infectious Disease Panels (1) Code No. Marker Category Panel Type Matrix IRB SG186-1 HbA1c Diabetes High Titre W/Blood Y SG336 Type I Diabetes Diabetes Diagnosis Y SG187-1/2 Diabetes Type II Diabetes Diagnosis Serum K2 EDTA Plasma / Serum SG316-2 FSH Endocrine Mixed Titre * Serum Y SG608-2 Procalcitonin Endocrine Mixed Titre Serum Y SG369-2 Progesterone Endocrine High Titre Serum Y SG490-2 SG360-2 SG355-2 SG362-2 SG321-2 SG358-2 NEW SG317-2 SHBG AFP CA125 CA15-3 CEA CA19-9 CYFRA 21-1 PSA Endocrine Oncology Oncology Oncology Oncology Oncology Oncology Oncology Mixed Titre * Mixed Titre * High Titre High Titre High Titre High Titre Mixed Titre * Mixed Titre Serum Serum Serum Serum Serum Serum Serum Serum Y Y Y Y Y Y Y Y Y * Many of the Mixed Titre samples fall within the clinically significant range
  • 10. Current Inventory | Clinical Samples Non-Infectious Disease Panels (2) Code No. Marker Category Panel Type Matrix IRB SG320-2 CRP Biochemistry Mixed Titre * Serum Y SG323-2 cTnI Cardiac Mixed Titre * Serum Y SG324-4 D Dimer Cardiac Low Titre Citrate Pl. Y SG587-2 Triglyceride Cardiac Mixed Titre * Serum Y SG312-2 Free T3 Thyroid Mixed Titre * Serum Y SG313-2 Free T4 Thyroid Mixed Titre * Serum Y TSH Thyroid Hepatic Impairment Organ Failure / Impairment Renal Failure Organ Failure / Impairment High Titre High Titre High Titre Y Y Y SG522 Alzheimer's Disease Neurological Diagnosis SG383-2 SG384-2 SG335-2 SG521-2 Pregnancy Pregnancy Coeliac Disease Crohn’s Pregnancy Pregnancy Autoimmune Autoimmune 1 Trimester rd 3 Trimester Diagnosis Diagnosis Serum Serum Serum Lith Hep / EDTA Plasma Serum Serum Serum Serum SG314-2 SG505-2 SG507-2 st * Many of the Mixed Titre samples fall within the clinically significant range Y Y Y Y Y
  • 11. Current Inventory | Clinical Samples Non-Infectious Disease Panels (3) Code No. Marker Category Panel Type Matrix IRB SG508-2 Allergy (Specific IgE+) Allergy Mixed Titre Serum Y d1 House Dust Mite, European (Dermatophagoides pteronyssinus) d2 House Dust Mite, American (Dermatophagoides farinae) e1 Cat dander (Felis domesticus) e3 Horse dander (Equus caballus) e5 Dog dander (Canis familiaris) e82 Rabbit epithelium (Oryctolagus cuniculus) f1 Egg White (Gallus spp.) f13 Peanut (Arachis hypogaea) f2 Cow's Milk (Bos spp.) f84 Kiwi (Actinidia deliciosa) g6 Timothy grass pollen (Phleum pratense) i3 Common wasp, Yellow jacket wasp venom (Vespula spp.) t2 Grey alder pollen (Alnus incana) t3 Common silver birch pollen (Betula verrucosa) t4 Hazel pollen (Corylus avellana)
  • 12. Current Inventory | Clinical Samples Normal, Health Donor Panels (1) Code No. Marker Category Panel Type SG375-2 Normal Healthy Donors Serum SG609-2 Normal, Female Healthy Donors Serum SG610-2 Normal, Male Healthy Donors Serum SG609-6 Normal, Female Healthy Donors Lith Hep Plasma SG610-6 Normal, Male Healthy Donors Lith Hep Plasma Matrix  25 donors, 2 x 1ml drawn from each donor  Male & female donors  Not viral tested  Minimum volume of 2ml  Collected and frozen within 24 hours  Age, Gender, Race, Collection Date  Non viral tested  Drawn from hospitalised non-cardiac patients  Minimum volume of 2ml  Collected and frozen within 24 hours  Age, Gender, Race, Collection Date, Confirmation of noncardiac status,  Non viral tested IRB N N N N N
  • 13. Our Capabilities | Specialty Blood Products  Normal serum and plasma and speciality products in a variety of anticoagulants  Range of volume from 1ml to full single Custom Plasma collection in FDA licensed facilities  Custom anticoagulant, capabilities of >500L per month serum / plasma units  Large scale collections possible >1,000 L  Custom control of the pre-analytical phase available “Packed” red cells  Available in bulk in K3EDTA
  • 14. How to Order Please get in touch to arrange a quote for any of our products. If you can’t find what you are looking for, take a look at some of our customised services:  Custom collections  Defibrination service  Heat inactivation  Pooling service  Custom testing / screening  Custom specifications for products requiring regular supply for production info@bbisolutions.com USA: 1-800-423-8199 Intl: +44 (0) 2920 747 232 Quote on ordering – NF JAN

×